Itoh K, Inoue K, Yanagiwara S, Kyoya H, Suzuki T
Department of Pharmaceutical Science, Akita University Hospital, Japan.
Biol Pharm Bull. 1999 Jan;22(1):77-9. doi: 10.1248/bpb.22.77.
A rapid and simple cytochrome P450 (CYP) 2C19 genotyping system was established by making several modifications in previously reported procedures. PCR conditions were modified to be capable of simultaneous amplification of CYP2C19m1 and CYP2C19m2 regions. Intensive bands of 169 bp for the CYP2C19m1 region and 329 bp for the CYP2C19m2 region with low background were obtained by using PCR condition involving an initial denaturation of 5 min at 94 degrees C, 35 cycles of 1 min at 94 degrees C; 1 min at 53 degrees C; 1 min at 72 degrees C, and final extension of 5 min at 72 degrees C. Next, the optimal restriction enzyme digestion conditions were determined by using PCR products from a subject of wt/wt genotype. Both products were completely digested with 5 U of the corresponding enzyme (Sma I for CYP2C19m1 and Bam HI for CYP2C19m2) for 1 h incubation at an optimal temperature. The incidence (16%; 5/32) of subjects homozygous for mutant alleles determined by an established assay system agreed well with the incidence of the poor metabolizer (PM) phenotype in the Japanese population. The established genotyping system would, therefore, be applicable to the clinical laboratory testing of patients with a PM phenotype of CYP2C19 to select appropriate and effective medication.
通过对先前报道的方法进行若干修改,建立了一种快速简便的细胞色素P450(CYP)2C19基因分型系统。对PCR条件进行了修改,使其能够同时扩增CYP2C19m1和CYP2C19m2区域。通过使用如下PCR条件获得了CYP2C19m1区域169 bp和CYP2C19m2区域329 bp的强条带且背景较低:初始变性在94℃下5分钟,94℃下1分钟、53℃下1分钟、72℃下1分钟进行35个循环,最后在72℃下延伸5分钟。接下来,通过使用野生型/野生型基因型受试者的PCR产物确定最佳限制性酶切条件。两种产物都用5 U相应的酶(CYP2C19m1用Sma I,CYP2C19m2用Bam HI)在最佳温度下孵育1小时进行完全消化。通过既定检测系统确定的突变等位基因纯合受试者的发生率(16%;5/32)与日本人群中慢代谢者(PM)表型的发生率非常吻合。因此,所建立的基因分型系统将适用于对CYP2C19的PM表型患者进行临床实验室检测,以选择合适有效的药物。